Year-end Sale % OFF 
Abstract
New and targeted treatment options in early-stage non-small cell lung cancer (NSCLC) patients have the potential to increase survival, but further characterization is needed to improve patient selection. Here, we present real-world patient characteristics, survival data, and disease-free survival (DFS) patterns of early-stage NSCLC patients treated in the county of Aarhus, Denmark.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
